Voloridge Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
50,582
-46,600
-48% -$1.31M 0.01% 685
2026
Q1
$2.77M Sell
97,182
-123,108
-56% -$4.2M 0.01% 780
2025
Q4
$8.71M Sell
220,290
-53,459
-20% -$1.96M 0.03% 627
2025
Q3
$9.65M Buy
273,749
+4,041
+1% +$139K 0.03% 548
2025
Q2
$8.84M Sell
269,708
-119,248
-31% -$3.88M 0.03% 582
2025
Q1
$12.5M Buy
388,956
+128,544
+49% +$4.77M 0.05% 496
2024
Q4
$7.96M Sell
260,412
-129,258
-33% -$4.16M 0.03% 643
2024
Q3
$10.9M Sell
389,670
-114,060
-23% -$2.81M 0.04% 563
2024
Q2
$11.5M Buy
503,730
+293,083
+139% +$6.76M 0.04% 533
2024
Q1
$6.41M Buy
210,647
+50,548
+32% +$1.69M 0.02% 586
2023
Q4
$5.71M Buy
160,099
+108,600
+211% +$4.04M 0.02% 587
2023
Q3
$2.26M Sell
51,499
-4,536
-8% -$221K 0.01% 892
2023
Q2
$2.77M Sell
56,035
-80,308
-59% -$3.7M 0.01% 884
2023
Q1
$5.65M Buy
136,343
+88,209
+183% +$3.66M 0.03% 637
2022
Q4
$2.14M Buy
+48,134
New +$2.01M 0.01% 944
2022
Q3
– Sell
-48,770
Closed -$1.99M – 1389
2022
Q2
$1.99M Sell
48,770
-8,445
-15% -$400K 0.01% 1016
2022
Q1
$3.76M Sell
57,215
-7,619
-12% -$494K 0.02% 738
2021
Q4
$4.51M Buy
64,834
+15,667
+32% +$1.14M 0.02% 764
2021
Q3
$3.42M Buy
49,167
+43,163
+719% +$3.32M 0.02% 839
2021
Q2
$476K Buy
+6,004
New +$436K ﹤0.01% 1448
2021
Q1
– Sell
-4,199
Closed -$234K – 1380
2020
Q4
$234K Sell
4,199
-3,121
-43% -$135K ﹤0.01% 1248
2020
Q3
$292K Sell
7,320
-54,135
-88% -$2.3M ﹤0.01% 1159
2020
Q2
$2.76M Buy
+61,455
New +$2.68M 0.03% 518

Other funds holding ATRC

Voloridge Investment Management's ATRC Position: Q2 2026 in Review

Voloridge Investment Management reduced its AtriCure (ATRC) stake by 48% in Q2 2026, selling an estimated $1.31M and leaving 50,582 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #685.

Voloridge Investment Management first reported a position in ATRC in Q2 2020 and has held it in 23 quarters since. The position peaked at $12.5M in Q1 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Voloridge Investment Management held 50,582 shares of AtriCure worth $1.42M as of Q2 2026.
  • Voloridge Investment Management sold 46,600 AtriCure shares in Q2 2026, an estimated $1.31M.
  • AtriCure made up 0.01% of Voloridge Investment Management's portfolio in Q2 2026, its #685 holding.
  • Voloridge Investment Management first reported a position in AtriCure in Q2 2020 and has held it in 23 quarters since.
  • Voloridge Investment Management's AtriCure position peaked at $12.5M in Q1 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.